S3 Ep14: Byoungseo Choi on Celltrion's Biosimilar Goals For 2030 - a podcast by Not So Different: a Podcast from The Center for Biosimilars

from 2020-07-19T11:00

:: ::

To learn more about Celltrion Healthcare, visit celltrionhealthcare.com.

You can learn more about the testing of Celltrion's infliximab biosimilar for the treatment of COVID-19 here.